Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site Sort descending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort descending Location Division Business Functional Area Date Posted
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
RLT Customer Service Coordinator Seoul South Korea International Innovative Medicines Sales Aug 27, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Sep 01, 2024
Patient Support Program Lead Seoul South Korea International Innovative Medicines Marketing Sep 24, 2024
P&R Manager Seoul South Korea International Innovative Medicines Market Access Sep 27, 2024
ASCVD Brand Manager Seoul South Korea International Innovative Medicines Marketing Sep 03, 2024
Sr. Medical Science Liaison, ASCVD Seoul South Korea International Innovative Medicines Research & Development Sep 05, 2024
Senior Patient Safety Specialist Seoul South Korea Development Innovative Medicines Research & Development Oct 20, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
Study Start-Up Lead Shanghai (Shanghai) China Development Innovative Medicines Research & Development Oct 22, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit & Finance Aug 29, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
PMO, Corporate Shanghai (Shanghai) China International Innovative Medicines BD&L & Strategic Planning Aug 08, 2024
PMO, CRM&IPA Shanghai (Shanghai) China International Innovative Medicines BD&L & Strategic Planning Aug 08, 2024
MSL Manager, RLT Shanghai (Shanghai) China International Innovative Medicines Research & Development Apr 18, 2024
Sr. Manager DDIT GF Sol.Del. China Shanghai (Shanghai) China Operations CTS Technology Transformation Sep 03, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Apr 29, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jul 29, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Apr 16, 2024
Principal Biostatistician Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jun 20, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
Senior Legal Counsel Shanghai (Shanghai) China Legal Innovative Medicines Legal & Intellectual Property & Compl. Jul 02, 2024
Associate Clinical Development Medical Director Shanghai (Shanghai) China Development Innovative Medicines Research & Development Aug 22, 2024
Medical Advisor Shanghai (Shanghai) China International Innovative Medicines Research & Development Jul 15, 2024
RLT HCS & Partnerships Head Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Sr Manager/Manager-Monitoring Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Jul 18, 2024
Senior Marketing Manager Shanghai (Shanghai) China International Innovative Medicines Marketing May 15, 2024
Head of Customer Strategy & Operations Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Center Operation Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development May 30, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)大区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 17, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development Oct 18, 2024
Head DPDAI China Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Jun 21, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only